the emcdda and the reitox network: towards quality achievement sandrine sleiman, scientific...
TRANSCRIPT
The EMCDDA and the Reitox network: towards quality achievement
Sandrine Sleiman, Scientific Committee, Palmela, February 2008
Contents
• National focal points (NFP)
• Operating framework
• Challenges
What is a NFP?
An information interface between the Member State and the EMCDDA. The NFPs play a double role:
• ‘National authority’ for providing national drug information to the EMCDDA (under national responsibility)
• ‘Ambassador’ of the EMCDDA at national level (under EMCDDA guidance)
Role of Reitox
Mechanism for collecting and exchanging information between the EMCDDA and 30 countries:
• 27 EU Member States
• Norway
• 2 candidate countries
European Commission
Prevention & Re-habilitation ActivitiesCoordination Unit
The REITOX Network
Austrian HealthInstitute
Scientific InstitutePublic Health
National Board ofHealth
National R&D Centrefor Welfare & Health
French Observatoryfor Drugs & DrugAddiction
Secretariat Nat. Drug Commission
Nat. Monitoring Centre for Drugs and Drug Addiction
State Centre for Drug abuse Prevention
Institute for TherapyResearch
University MentalHealth ResearchInstitute
Health ResearchBoard
Estonian Drug Monitoring Centre
Min. of HealthNat. Centre for Epidemiology
Portuguese Institutefor Drugs & DrugAddiction
Government Deleg.to the National Planon Drugs
National Instituteof Public Health
Dept Min. of Health
Nat. Bureau for Drug Prevention
Institute Public Health
Board of Ministers for Drug Dependencies and Drug Control
European Commission
Direction de laSanté
Trimbos Institute SIRUSMin. of Health Drug Control Department
National Commission for Dependencies
National Centre for Addictions
National Anti-Drugs Agency
TurkeyTADOC – Turkish Academy against Drugs and Organised Crime
CroatiaOffice for Combating Narcotic Drug Abuse
The future new members of EMCDDA
And Western Balkan countries
Basis for Reitox cooperation with NFPs
• Founding Council Regulation of the EMCDDA
• Operating framework for the Reitox system
• New reporting structure and tools
• EMCDDA and Reitox work programmes
• Grant agreements
• Guidelines for reporting
How does a NFP work?
• Appointed by MS (national responsibility)
• Funded by MS, with EMCDDA co-financing
• Grant agreement for an action, 50% co-financing, with max. 97.000 € per country (2007)
• Procedure for definition work programme
Working towards a high-quality NFP- institutional challenges
• Institutional framework
• Legal base
• Clear mandate (incl. national responsibilities)
• Validity period of NFP nomination
• National political support
• Evidence-based decision-making with regard to drugs and drug addiction
Working towards a high-quality NFP
- operational challenges
• NFP competences should mirror the EMCDDA subject areas
• Cooperation with national/regional drug information network(s) and scientific community
• Interagency cooperation
• Access to national and regional data
• Human and financial resources
The new Reitox operating framework
• Result of a 2-y process: evaluation, working group new operating framework, working group new reporting tools
• Reporting tools• Grant agreement• Tasking process• Capacity building
Guidelines for national reportingSummary
Part A: New Developments and Trends
1. National policies and context
2. Drug Use in the Population
3. Prevention
4. Problem Drug Use
5. Drug-Related Treatment
6. Health Correlates and Consequences
7. Responses to Health Correlates and Consequences
8. Social Correlates and Consequences
9. Responses to Social Correlates and Consequences
10. Drug Markets
Part B – Selected Issues
11. Sentencing statistics
Part C
14. Bibliography
15. Annexes
Outputs of REITOX cooperation
Information collected and analysed atnational level and submitted to the EMCDDA
• National Reports, Structured Questionnaires, Standard Tables
• Implementation of the epidemiological key indicators• Data input into EMCDDA information systems• Early warnings on new synthetic drugs to the EMCDDA• Press clippings and replies to ad hoc requests
Reitox network challenges
Quality Assurance Policy
- Quality reports
- Implementation Needs Profiles
RTX Academy
- Motivating by supporting national needs
- Forging networking spirit
Data consistency
Quality check
Quality assessment
Process
Exploitation
Quality feedback
Since 2001 success…
• Generally recommendation for improvement are applied regarding adherence to guidelines:
- General layout - References to standard tables and structured questionnaires- Sources and use of Harvard for bibliography- Methodological information …- Efforts in writting the National report
Gaps to fill in…
• Respect of deadline • Conciseness• Weaknesses about lack of insight on trends
and interpretation of results …• In some countries, it is still too early to have
many information on trends
2007 Reitox academies
• Reitox Academy on cannabis prevention and treatment (29-30, March 2007)
• Reitox Academy on public expenditure analysis in the field of drugs (May (TBC), Luxembourg)
• Reitox Academy Fonte training: introductory course (22nd May, heads of NFP meeting, Lisbon)
• Reitox Academy Fonte training: specialised course (8th, June, Ankara, Turkey)
• Reitox Academy on science-based practices (12-13 Sep, Oslo, Norway)
2008 and beyond
• RTX Academy on Media relations, TDI, analysis of TDI data using different methodologies, qualitative and quantitative and focus on data coverage.
• Towards further improvements of the academies:• to link more regularly RTX Academies with Selected Issues • to organise Academies for a broader audience (national
experts)• to provide with additional features (MP3 files)• updated strategy document on RTX Academy training
programme
To participate in the RTX network and to face challenges, usefulness and added values of the network should be perceived at national level